NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (DNA, Library Preparation, Quality Control), Technology, Application, End-User - Global Forecast 2024-2030

[197 Pages Report] The NGS Sample Preparation Market size was estimated at USD 2.40 billion in 2023 and expected to reach USD 2.78 billion in 2024, at a CAGR 16.01% to reach USD 6.80 billion by 2030.

Next Generation Sequencing (NGS) sample preparation is essential and primary step in library preparation and is necessary for various diagnostic analyses. The increasing complexity of laboratory workflows and the need to reduce sample processing time are raising the need for NGS sample preparation solutions. Growing applications of NGS in clinical diagnostics and personalized medicine are increasing the requirement for NGS sample preparation techniques. However, high hardware and software infrastructure costs may limit their adoption by the end users. Moreover, the technological advancements in NGS sample preparation platforms and ongoing collaborations between companies to develop NGS sample preparation platforms are expected to expand the usage of NGS sample preparation systems and solutions.

The NGS sample preparation market is evolving in the Americas owing to the presence of a well-established pharmaceutical sector and local and international companies providing a wide range of products tailored to specific applications. These companies in the region offer a variety of sample preparation solutions ranging from reagents to automated platforms and provide end users with high-quality products that meet their specific requirements. The NGS Sample Preparation Market in APAC is growing owing to the rising prevalence of chronic diseases and the growing need for early detection and diagnosis of diseases. The NGS sample preparation market in Europe, the Middle East, and Africa (EMEA) is developing due to improved access to NGS technologies, associated infrastructure, and healthcare systems development. Additionally, increased investment in diagnostic testing capabilities and the development of innovative sample preparation platforms are expected to create lucrative opportunities to adopt NGS sample preparation solutions worldwide.

The market dynamics represent an ever-changing landscape of the NGS Sample Preparation Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Increasing prevalence of infectious diseases and rising need for early disease diagnosis
  • Favorable investment landscape in NGS for the research and development of new treatments
  • Emerging use of NGS sequencing technology in agriculture for sustainable productivity
• Market Restraints
  • High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
• Market Opportunities
  • Technological advancement in NGS sample preparation platforms
  • Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
• Market Challenges
  • Limited availability of skilled professionals in medium and small size laboratories

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the NGS Sample Preparation Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the NGS Sample Preparation Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the NGS Sample Preparation Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

• Agilent enhances user experience in NGS sample preparation workflow

  Agilent Technologies, Inc. recently launched a new automation solution for next-generation sequencing (NGS) sample preparation workflow. The solution gives scientists a quick and efficient way to prepare samples for NGS analysis. The automated workflow includes a comprehensive set of tools, such as Agilent's Nextera XT Index Kit, Magbead technology, and its EZ Bead instrument. [Published On: May 09, 2023]

• INTEGRA Biosciences Acquires Miroculus

  Integra Biosciences recently announced a strategic acquisition of Miroculus, a company specializing in digital microfluidics-based solutions for single-cell molecular diagnostics. Integra has gained access to innovative technologies enabling them to expand their capabilities within the NGS sample preparation market. This acquisition is an important step in strengthening Integra's competitive position and presence in this growing market and providing customers with enhanced products and service offerings. [Published On: March 16, 2023]

• Ultima Genomics Partners with New England Biolabs to Expand Research Applications on Ultima Sequencers

  New England Biolabs (NEB) and Ultima Genomics are pleased to announce their new partnership, through which NEB can provide Ultima Genomics with high-quality reagents and kits for sample preparation for Next Generation Sequencing (NGS). This partnership can provide NGS researchers with more efficient and affordable sample preparation options. The collaboration of these two companies offers a unique combination of experience in the life sciences industry and an innovative approach to developing NGS solutions. [Published On: February 06, 2023]

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the NGS Sample Preparation Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

The report delves into recent significant developments in the NGS Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biological Materials Inc., Aurora Biomed Inc., Beckman Coulter by Danaher Corporation, BGI Group, Bio-Rad Laboratories, Inc., BioDynami, Eppendorf SE, Eurofins Genomics LLC, F. Hoffmann-La Roche Ltd., FORMULATRIX, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Macrogen Inc., Magen Biotechnology Co., Ltd., MCLAB, Merck KGaA, New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., Promega Corporation, Psomagen, Inc., Qiagen N.V., SPT Labtech Ltd, Standard BioTools Inc., Sysmex Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Zymo Research Corporation.

This research report categorizes the NGS Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Reagents & Consumables
  • Workstations
• Workflow
  • DNA
    • Human Whole Genome Sequencing (WGS)
    • Targeted Sequencing
    • Whole Exome Sequencing (WES)
  • Library Preparation
  • Quality Control
  • RNA
    • Gene Expression Analysis
    • Whole Transcriptome Sequencing
  • Target Enrichment
    • Targeted Seq
    • WES
    • Whole Exome Sequencing (WES)
• Technology
  • Ion Semiconductor Sequencing
  • Nanopore Sequencing
  • Sequencing by Synthesis (SBS)
  • Single-molecule real-time (SMRT) Sequencing
• Application
  • Agricultural & Animal Research
  • Disease Diagnostics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • Reproductive Health Diagnostics
  • Drug Discovery
• End-User
  • Academic Institutes and Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?